SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence.
Saved in:
| Title: | SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence. |
|---|---|
| Authors: | Alfonso Arvez MJ; Monash Institute of Pharmaceutical Sciences, Centre for Medicine Use and Safety, Parkville, Australia., Tan GSQ; Monash Institute of Pharmaceutical Sciences, Centre for Medicine Use and Safety, Parkville, Australia., Leung MTY; Monash Institute of Pharmaceutical Sciences, Centre for Medicine Use and Safety, Parkville, Australia., Ademi Z; Monash Institute of Pharmaceutical Sciences, Centre for Medicine Use and Safety, Parkville, Australia., Bell JS; Monash Institute of Pharmaceutical Sciences, Centre for Medicine Use and Safety, Parkville, Australia. |
| Source: | Journal of diabetes research [J Diabetes Res] 2025 Oct 16; Vol. 2025, pp. 5888495. Date of Electronic Publication: 2025 Oct 16 (Print Publication: 2025). |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101605237 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6753 (Electronic) NLM ISO Abbreviation: J Diabetes Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2314-6753 |
|---|---|
| DOI: | 10.1155/jdr/5888495 |
